March 8, 2022
RFA-OD-22-003 - Center for Coordination of Analytics, Science, Enhancement , and Logistics (CASEL) in Tobacco Regulatory Science (U54) Clinical Trial Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)
National Institute on Drug Abuse (NIDA)
This Notice is to inform prospective applicants about the pre-application webinar for the Funding Opportunity Announcement (FOA) RFA-OD-22-003, “Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed)” and the availability of a Frequently Asked Questions (FAQ) document.
Webinar Information
Date: Monday, March 21, 2022
Time: 3:30 p.m. to 5:00 p.m. (Eastern Time)
NIH and FDA staff will provide an overview of RFA-OD-22-003, the application review process, and answer questions from prospective applicants. The webinar is open to all prospective applicants, and participation in the webinar is not a prerequisite to applying. All interested individuals are encouraged to register in advance to attend the webinar.
The webinar registration link is https://nih.zoomgov.com/meeting/register/vJIscO2qrz4iE8IfRXusdqpugk4ocjY0s6w. Additional information about the webinar can be found at: https://prevention.nih.gov/tobacco-regulatory-research/funding-opportunities/pre-application-webinar-center-coordination-analysis-science-enhancement-and-logistics-casel. The webinar will be captioned in real-time. Individuals needing reasonable accommodations should contact [email protected]. Requests should be made at least five business days before the event. After the webinar, webinar slides and a captioned copy of the event will be posted on the pre-application webinar site.
Prospective applicants are encouraged to submit questions regarding the FOA in advance of the webinar to [email protected] by March 14, 2022, by 5:00 p.m. ET. While an effort will be made to include all questions in the webinar, presentations, or discussion, it is possible that not all will be addressed during the meeting due to time constraints.
Frequently Asked Questions (FAQ)
A Frequently Asked Questions (FAQ) document to address common questions from potential applicants regarding the FOA is available at: https://prevention.nih.gov/tobacco-regulatory-research/funding-opportunities/pre-application-webinar-center-coordination-analysis-science-enhancement-and-logistics-casel.
The FAQs may be subsequently updated without notice. Prospective applicants are encouraged to visit this site often.
Tobacco Regulatory Science Program (TRSP)
Office of Disease Prevention
Telephone: 301-451-7464
Email: [email protected]
Please direct all inquiries concerning the U54 RFA to:
Heather Kimmel, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-0036
Email: [email protected]
and Human Services (HHS)
